Adipose tissue and inflammatory bowel disease pathogenesis
about
Advances in nutritional therapy in inflammatory bowel diseases: ReviewThe role of physical exercise in inflammatory bowel diseaseMechanisms and metabolic implications of regional differences among fat depotsAdipokines and the role of visceral adipose tissue in inflammatory bowel diseaseThe Changing Phenotype of Inflammatory Bowel DiseaseBeneficial Effect of Voluntary Exercise on Experimental Colitis in Mice Fed a High-Fat Diet: The Role of Irisin, Adiponectin and Proinflammatory BiomarkersAdipose-tissue and intestinal inflammation - visceral obesity and creeping fatSystematic review: body composition in adults with inflammatory bowel disease.Measures of obesity and risk of Crohn's disease and ulcerative colitis.Moderate exercise training attenuates the severity of experimental rodent colitis: the importance of crosstalk between adipose tissue and skeletal muscles.Inflammatory cytokine gene expression in mesenteric adipose tissue during acute experimental colitisResults of the 4th scientific workshop of the ECCO (I): pathophysiology of intestinal fibrosis in IBD.Immunopathogenesis of IBD: current state of the art.The influence of anti-TNF therapy on the magnetic resonance enterographic parameters of Crohn's disease activity.The utility of apoptosis inhibitor of macrophages as a possible diagnostic marker in patients with Crohn's disease.Elevated peripheral frequencies of Th22 cells: a novel potent participant in obesity and type 2 diabetesThe Role of Intestinal Alkaline Phosphatase in Inflammatory Disorders of Gastrointestinal Tract.The bone and fat connection in inflammatory bowel diseases.Mechanisms of initiation and progression of intestinal fibrosis in IBD.Dietary management of IBD--insights and advice.Extraintestinal Manifestations Are Common in Obese Patients with Crohn's Disease.An evaluation of the feasibility and validity of a patient-administered malnutrition universal screening tool ('MUST') compared to healthcare professional screening in an inflammatory bowel disease (IBD) outpatient clinic.Visceral Adiposity, Genetic Susceptibility, and Risk of Complications Among Individuals with Crohn's Disease.Hypertrophic Mesenteric Adipose Tissue May Play a Role in Atherogenesis in Inflammatory Bowel Diseases.Reciprocal Inflammatory Signaling Between Intestinal Epithelial Cells and Adipocytes in the Absence of Immune Cells.Crohn's Disease Disturbs the Immune Properties of Human Adipose-Derived Stem Cells Related to Inflammasome Activation.High-fat diet-induced obesity exacerbates inflammatory bowel disease in genetically susceptible Mdr1a-/- male mice.Excessive weight gain is associated with an increased risk for pouch failure in patients with restorative proctocolectomy.Lipidomic Profiling in Inflammatory Bowel Disease: Comparison Between Ulcerative Colitis and Crohn's Disease.Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab.Postoperative excessive gain in visceral adipose tissue as well as body mass index are associated with adverse outcomes of an ileal pouch.Visceral Adipose Tissue in Patients with Crohn's Disease Correlates with Disease Activity, Inflammatory Markers, and Outcome.Mesenteric Adipose-derived Stromal Cells From Crohn's Disease Patients Induce Protective Effects in Colonic Epithelial Cells and Mice With Colitis.Obesity in Inflammatory Bowel Disease: Gains in Adiposity despite High Prevalence of Myopenia and Osteopenia
P2860
Q26774563-AE75A636-490A-4E21-9EDF-EDB4FAFBA279Q26865777-4129D958-24C1-44D1-8627-3903B8673876Q27004113-A93D9359-BC76-4EFB-9CE2-90A3395026EBQ28070229-358BD98A-D53A-46C1-AE97-B1C71D34E110Q28354092-4B48CEFE-0514-4E73-96EE-417E7514FAB7Q33616994-A7D0DBE6-1649-446D-B51A-A96FD6C3811FQ34239249-693417EA-2434-41FF-9702-FB5AB6FC39D2Q34771160-187796FE-2AD5-4634-B203-99D16153B332Q35020014-49CEC815-2404-4E86-AA08-F01E3ACA54A4Q35037497-56600F77-2F2A-4F7E-AF60-9A3C0810CA8BQ35080569-69B97709-753E-4237-BD7C-CC5F734F87E4Q35147482-F70208A1-B37D-4FA7-BB42-5B3A5EDD4EA4Q35857951-1AECD1BC-0459-46C0-ACF2-283761367712Q36095803-A74CA7CC-9226-4876-AA6B-58A0B132DFBFQ36305141-3A955FD4-9C58-4906-AE3D-97617F6D556BQ37490734-2A0B6F32-28E6-4111-B467-788CA25F41BEQ37683531-F342553F-8887-4C8B-9B71-6E100DB7826FQ38225220-964F42BB-10FD-4640-8933-78D0CC3081F8Q38293779-2D14504F-E9DE-4666-A868-463BCB25F4D0Q38342102-4B702797-B3EE-4339-9725-8F664C0A7E0DQ38686671-8CAFFDB3-DA02-47BE-A248-FFC278CB3B15Q38741475-47AEEE61-B4E7-46A3-8813-959D264103F4Q39148616-B04AF632-30CD-4596-AFF4-7A37CC564DA8Q39504700-1978F48D-0586-420F-BA27-AB967BB3811FQ41688465-3E148CC5-EF98-41B8-86AF-A56CEF939A42Q42376230-388DA32D-655C-4CEC-A6F6-39FD12DEEABBQ44108043-FB459F2B-F750-47DB-B7F0-66E6B359E586Q45963829-042EA578-98E2-45E7-930F-3C9DB318B6EEQ46740197-69BAC73F-69DF-4355-BEA8-2A59BD22916AQ47118783-905D2FE1-113C-42CE-8B31-ECBAD6DCA2DDQ47272488-61496680-BDA6-4C58-A186-D828FAB21D9DQ52863802-57286B5F-05DF-46F4-9057-5B0C606C07B7Q55197461-A910131C-5A7A-4327-83D8-CDEFBC392C03Q58773411-417A9A9C-2E68-4297-BC7B-852D1C95835C
P2860
Adipose tissue and inflammatory bowel disease pathogenesis
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Adipose tissue and inflammatory bowel disease pathogenesis
@ast
Adipose tissue and inflammatory bowel disease pathogenesis
@en
type
label
Adipose tissue and inflammatory bowel disease pathogenesis
@ast
Adipose tissue and inflammatory bowel disease pathogenesis
@en
prefLabel
Adipose tissue and inflammatory bowel disease pathogenesis
@ast
Adipose tissue and inflammatory bowel disease pathogenesis
@en
P2093
P2860
P356
P1476
Adipose tissue and inflammatory bowel disease pathogenesis
@en
P2093
Charalabos Pothoulakis
Christopher Fink
Iordanes Karagiannides
Kyriaki Bakirtzi
P2860
P304
P356
10.1002/IBD.22893
P577
2012-03-08T00:00:00Z